| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hypertension, Vol 4, 125-131, Copyright © 1982 by American Heart Association
PW de Leeuw and WH Birkenhager
To investigate the relationship between sympathetic activity and blood flow
in the kidney during propranolol treatment, 55 patients with uncomplicated
essential hypertension were studied. Twenty-five of them had been treated
with propranolol (average daily dose 240 mg) for about two weeks; the
others served as untreated controls. In all patients renal arteriography
was carried out, after which renal plasma flow (125I-hippuran clearance),
cortical blood flow (xenon-washout), and renal release of norepinephrine
and renin were measured. In the propranolol group, renal plasma flow had
also been determined before treatment. Cardiac output (dye-dilution) and
creatinine clearance were measured both before as well as during therapy.
In untreated hypertensives renal cortical blood flow was reduced to about
80% of what was predicted for the age level. On the basis of their changes
in blood pressure, patients who were treated with propranolol were divided
into responders (n = 15) and nonresponders (n = 10). Despite a similar fall
in cardiac output in both subgroups, renal blood flow remained unchanged in
responders, while it fell in nonresponders. In addition, renal
norepinephrine release was significantly higher in nonresponders than in
responders, while renin release in nonresponders was markedly suppressed.
It may be concluded that sympathetic activity is an important determinant
of renal (cortical) blood flow in essential hypertension. The effect of
propranolol on the renal circulation depends, to some extent, on its
unmasking of prevailing alpha- adrenergic tone. However, when blood
pressure falls, an additional mechanism may be operative to cause renal
vasodilation.
ARTICLES
Renal response to propranolol treatment in hypertensive humans
This article has been cited by other articles:
![]() |
S. C. Textor, A. C. Novick, D. R. Steinmuller, and S. B. Streem Renal Failure Limiting Antihypertensive Therapy as an Indication for Renal Revascularization: A Case Report Arch Intern Med, November 1, 1983; 143(11): 2208 - 2211. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1982 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |